Reify Health logoCompany profile

Reify Health

Reify Health has raised $478M in funding through multiple rounds: $30M Series B (Aug 12, 2020), $220M Series C (Aug 10, 2021), and $220M Series D (Apr 21, 2022). Key investors include Dragoneer Investment Group, Altimeter Capital, Coatue, Battery Ventures, and Iconiq Capital. Reify Health, headquartered in Boston, United States, provides AI-enhanced mobile health solutions for clinical trials, including patient recruitment, engagement, and custom mobile health algorithms, enabling researchers and scientists to accelerate trial processes and improve patient outcomes.

Back to profiles

Quick facts

Total funding
$478M
Headquarters
Boston, United States

Notable investors

  • Dragoneer Investment Group
  • Altimeter Capital
  • Coatue
  • Battery Ventures
  • Iconiq Capital

Reach buyers like Reify Health.

The 14-day trial ships every feature, no card required.